Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat Tauopathies

201970 citationsJournal Articlegreen Open Access

Authors

Gesine Respondek · German Center for Neurodegenerative Diseases

Max‐Joseph Grimm · German Center for Neurodegenerative Diseases

Ines Piot · German Center for Neurodegenerative Diseases

Thomas Arzberger · Ludwig-Maximilians-Universität München

Yaroslau Compta · Biomedical Research Networking Center on Neurodegenerative Diseases

Elisabet Englund · Lund University

Leslie W. Ferguson

Abstract

The new diagnostic category "probable 4R-tauopathy" showed high specificity and may be suitable for the recruitment of patients with progressive supranuclear palsy and corticobasal degeneration into therapeutic trials targeting 4R-tauopathy. The low sensitivity underpins the need for diagnostic biomarkers. © 2019 International Parkinson and Movement Disorder Society.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Alzheimer's disease research and treatments

Publication Details

Published in: Movement Disorders

Volume 35, Issue 1, pp. 171-176

DOI: 10.1002/mds.27872

Field-Weighted Citation Impact: 6.12

Command Palette

Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat Tauopathies

Authors

Abstract

Topics & Keywords

Publication Details